Medical Grand Rounds - "CRISPR for Clinicians"

Friday, May 13, 2022 | 12 p.m. - 1 p.m.
Microsoft Teams

Presenter: Wayne W. Grody, MD, PhD, Professor Medical Genetics and Molecular Pathology, Departments of Pathology & Laboratory Medicine, Pediatrics, and Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA

At the conclusion of this activity, participants should be able to:

  1. Incorporate the scientific principles behind the current revolution in gene editing and its potential to produce highly personalized therapies for cancer and genetic diseases.
  2. Confront and analyze the thorny ethical implications of this powerful new technology.
  3. Counsel patients on the current state of the art and potential clinical utility of gene editing technology for diagnosis and treatment of genetic, neoplastic, and infectious diseases.

Date, Time & Location:

Friday, May 13, 2022 at 12:00 p.m.
Microsoft Teams - E-mail to be included

This program is intended for: Physicians, Advanced Practice Providers, Fellows, Residents, Medical and Nursing Students, and other Ancillary Healthcare Professionals.

Accreditation Statement
“The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”
Designation Statement
“The Guthrie Clinic designates this live activity for a maximum of (1.0) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”
Disclosure Statement
“Faculty and all others who have the ability to control the content of continuing medical education activities provided by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent relevant financial relationships related to this educational activity.” “The presenting faculty/planning committee for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”